Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?
Allogeneic hematopoietic stem cell transplantation (HSCT) is an established curative treatment that has significantly improved clinical outcome of pediatric patients with malignant and non-malignant disorders. This is partly because of the use of safer and more effective combinations of chemo- and s...
Saved in:
Main Authors: | M. Y. Eileen C. van der Stoep (Author), Lisa V. E. Oostenbrink (Author), Robbert G. M. Bredius (Author), Dirk Jan A. R. Moes (Author), Henk-Jan Guchelaar (Author), Juliette Zwaveling (Author), Arjan C. Lankester (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling Long-Term Erythropoietic Recovery After Allogeneic Stem Cell Transplants in Pediatric Patients
by: Erik G. J. von Asmuth, et al.
Published: (2020) -
Chronic autoimmune urticaria : Where we stand ?
by: Goh C, et al.
Published: (2009) -
Diabetes Care in Iran: Where We Stand and Where We Are Headed
by: Sina Noshad, et al.
Published: (2016) -
Violence: where do we stand?
by: Wasantha Gunathunga
Published: (2001) -
Where are we standing in occupational cardiology?
by: Uğur Nadir Karakulak
Published: (2015)